Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.
Clinical trial NCT03172208 · COMPLETED
Trial details
- NCT number
- NCT03172208
- Sponsor
- Ablynx, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-05
- Primary completion
- 2017-10-19
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.